Procyon is a new cancer diagnostics spinout from Queen Mary University of London which has just completed an oversubscribed ...

Announced at the House of Lords, findings from the paper in The Lancet: Healthy Longevity demonstrate that the intervention, ...

While the study did not find a “hyperrealism effect” from the AI voices, it did find that voice clones can sound as real as ...

The pioneering study uses a new approach to detect the presence of circulating tumour DNA (ctDNA) to accurately identify ...

Rapalink-1, the new drug studied by the team, is a next-generation TOR inhibitor currently under investigation for cancer therapy. The researchers found that rapalink-1 not only slowed aspects of ...

Queen Mary University of London has partnered with the MassChallenge startup accelerator to offer a new route to impact for ...

A podcast that uncovers London’s hidden Cockney Yiddish culture, hosted by Queen Mary historians Professor Nadia Valman and ...

Queen Mary University of London and Barking and Dagenham Council have launched a major new partnership to tackle local health ...

Queen Mary University of London and Barking and Dagenham Council have launched a major new partnership to tackle local health and wellbeing challenges in the community.